Pain Control after Root Canal Treatment
- Registration Number
- CTRI/2019/08/020507
- Lead Sponsor
- Pratyasha Kaushik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients above 18 years of age.
Patients presenting with pain associated with irreversible pulpitis in mandibular molars with no clinical or radiographic signs or symptoms of acute or chronic apical periodontitis.
No history of taking analgesics in the previous 12 hours prior to presenting for treatment.
Patients presenting with American Society of Anesthesiologists I or II medical history.
Patients providing informed consent.
Patients who can read and understand the pain scoring criteria.
Presence of any systemic disorder or sensitivity or allergy that prevents the use of Proteolytic enzymes and NSAIDs.
Patients having hepatic and renal disorders.
Presence of periapical radiolucency and swelling or any other condition that prevents single-visit root canal treatment.
Patients having teeth not suitable for restoration, or having serious periodontal disease that render the teeth unsuitable for endodontic treatment.
Pregnant or lactating patients.
Teeth will be excluded if there is any overestimation of the working length, inadvertent overinstrumentation through the apical foramen, or extension of the root filling material beyond the working length.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serratiopeptidase may prove to be an effective anti-inflammatory and analgesic agent for post-endodontic pain following single visit root canal treatmentTimepoint: Single dose immediately after endodontic treatment
- Secondary Outcome Measures
Name Time Method Serratiopeptidase may prove to be as effective as ibuprofen for post-endodontic pain following single visit root canal treatmentTimepoint: Single dose immediately after endodontic treatment